Biofilm prevention concentration of clarithromycin against clinically relevant species of nontuberculous mycobacteria

CONCLUSIONS: These results open the possibility of using macrolides for the prevention of biofilm development in patients with a risk of developing NTM disease.PMID:38602224 | DOI:10.37201/req/014.2024

Source: Revista Espanola de Quimioterapia - April 11, 2024 Category: Drugs & Pharmacology Authors: A Senhaji-Kacha A Akir A Broncano-Lavado J Esteban Source Type: research